BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 26119402)

  • 1. Complement C4a inhibits the secretion of hepatitis B virus screened by surface-enhanced laser desorption ionization time-flight mass spectrometry-based ProteinChip analysis.
    Song YN; Zhang GB; Hu XQ; Lu YY; Zhao Y; Yang Y; Yang YF; Zhang YY; Hu YY; Su SB
    Proteomics Clin Appl; 2015 Dec; 9(11-12):1097-104. PubMed ID: 26119402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Serum Markers for Monitoring the Progression of Hepatitis B Virus-Associated Chronic Hepatic Lesions to Liver Cirrhosis.
    Wu C; Liu L; Zhao P; Tang D; Yao D; Zhu L; Wang Z
    Gut Liver; 2015 Sep; 9(5):665-71. PubMed ID: 25963079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of apoliprotein A1 down-regulated by Hepatitis B virus.
    Wang Y; Hao J; Liu X; Wang H; Zeng X; Yang J; Li L; Kuang X; Zhang T
    Lipids Health Dis; 2016 Mar; 15():64. PubMed ID: 27015844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference in serum complement component C4a levels between hepatitis C virus carriers with persistently normal alanine aminotransferase levels or chronic hepatitis C.
    Imakiire K; Uto H; Sato Y; Sasaki F; Mawatari S; Ido A; Shimoda K; Hayashi K; Stuver SO; Ito Y; Okanoue T; Tsubouchi H
    Mol Med Rep; 2012 Aug; 6(2):259-64. PubMed ID: 22614103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The differential diagnostic model for serous peptidomics in HBV carriers established by MALDI-TOF-MS analysis.
    Tian L; Wang Y; Xu D; Gao Y; Wen X; Tian Y
    Clin Biochem; 2014 Jan; 47(1-2):56-62. PubMed ID: 24183880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic profiling of heterotopic heart-transplanted rats using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry: potential biomarkers and drug targets.
    Bao Y; Xiu DR; Zhang L
    J Int Med Res; 2013 Jun; 41(3):628-35. PubMed ID: 23613499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of serum levels of complement C4a desArg with pathologically estimated severity of glomerular lesions and mesangial hypercellularity scores in patients with IgA nephropathy.
    Sogabe A; Uto H; Kanmura S; Nosaki T; Oyamada M; Tokunaga K; Nishida C; Fukumoto M; Oku M; Nishimoto K; Takenouchi S; Ido A; Shimada Y; Tsubouchi H
    Int J Mol Med; 2013 Aug; 32(2):307-14. PubMed ID: 23708385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of complement component 2 expression by hepatitis B virus contributes to the viral persistence in chronic hepatitis B patients.
    Ning G; Zhen LM; Xu WX; Li XJ; Wu LN; Liu Y; Xie C; Peng L
    J Viral Hepat; 2020 Oct; 27(10):1071-1081. PubMed ID: 32384193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LHBs can elevate the expression of MDR1 through HIF-1α in patients with CHB infection: a comparative proteomic study.
    Li S; Yang Y; Ding X; Yang M; She S; Peng H; Xu X; Ran X; Li S; Hu P; Hu H; Zhang D; Ren H
    Oncotarget; 2017 Jan; 8(3):4549-4562. PubMed ID: 27999186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients].
    Rüzgar M; Cetin Akhan S; Vahaboğlu H
    Mikrobiyol Bul; 2008 Apr; 42(2):283-91. PubMed ID: 18697426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum peptide profiles during progression of chronic hepatitis B virus infection to liver failure.
    Han T; Liu H; Yu ZL; Li J; Wang L; Xiao SX; Li Y; Yu ML
    J Viral Hepat; 2010 Mar; 17 Suppl 1():18-23. PubMed ID: 20586930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus suppresses complement C9 synthesis by limiting the availability of transcription factor USF-1 and inhibits formation of membrane attack complex: implications in disease pathogenesis.
    Baidya A; Khatun M; Mondal RK; Ghosh S; Chakraborty BC; Mallik S; Ahammed SKM; Chowdhury A; Banerjee S; Datta S
    J Biomed Sci; 2022 Nov; 29(1):97. PubMed ID: 36376872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSPB1 is an intracellular antiviral factor against hepatitis B virus.
    Tong SW; Yang YX; Hu HD; An X; Ye F; Ren H; Li SL; Zhang DZ
    J Cell Biochem; 2013 Jan; 114(1):162-73. PubMed ID: 22887120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in the Iron Homeostasis Network of Hepatocytes Caused by Hepatitis B Virus.
    Hou SW; Wang ZF; Guan SH; Yang K; Wang Q; Chen LW; Zhang H; Wang X; Duan YL; Pan ZL
    Clin Lab; 2019 Apr; 65(4):. PubMed ID: 30969090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum proteomic profiling reveals that pretreatment complement protein levels are predictive of esophageal cancer patient response to neoadjuvant chemoradiation.
    Maher SG; McDowell DT; Collins BC; Muldoon C; Gallagher WM; Reynolds JV
    Ann Surg; 2011 Nov; 254(5):809-16; discussion 816-7. PubMed ID: 22005152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
    J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA expression of glucocorticoid receptor and serological and virological markers of chronic hepatitis B.
    Mei B; Chen Y; Liu W; Li L; Wang C
    Mol Med Rep; 2015 Mar; 11(3):2215-20. PubMed ID: 25394950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput matrix-assisted laser desorption ionization-time of flight mass spectrometry as an alternative approach to monitoring drug resistance of hepatitis B virus.
    Rybicka M; Stalke P; Dreczewski M; Smiatacz T; Bielawski KP
    J Clin Microbiol; 2014 Jan; 52(1):9-14. PubMed ID: 24068014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune-driven adaptation of hepatitis B virus genotype D involves preferential alteration in B-cell epitopes and replicative attenuation--an insight from human immunodeficiency virus/hepatitis B virus coinfection.
    Mondal RK; Khatun M; Ghosh S; Banerjee P; Datta S; Sarkar S; Saha B; Santra A; Banerjee S; Chowdhury A; Datta S
    Clin Microbiol Infect; 2015 Jul; 21(7):710.e11-20. PubMed ID: 25882358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.